<?xml version="1.0" encoding="UTF-8"?><CAS version="2"><uima.cas.Sofa _indexed="0" _id="1" sofaNum="1" sofaID="_InitialView" mimeType="text" sofaString="P10964995A2152 Taken together, they uphold the emerging concern that women with ER(+) cancers may not benefit significantly from endocrine treatment if the tumors also overexpress HER-2."/><uima.tcas.DocumentAnnotation _indexed="1" _id="8" _ref_sofa="1" begin="0" end="186" language="x-unspecified"/></CAS>